0001493152-22-001379.txt : 20220118 0001493152-22-001379.hdr.sgml : 20220118 20220118060715 ACCESSION NUMBER: 0001493152-22-001379 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220118 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220118 DATE AS OF CHANGE: 20220118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensysce Biosciences, Inc. CENTRAL INDEX KEY: 0001716947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822755287 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38306 FILM NUMBER: 22533466 BUSINESS ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 263-4196 MAIL ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Leisure Acquisition Corp. DATE OF NAME CHANGE: 20170913 8-K 1 form8-k.htm
0001716947 false 0001716947 2022-01-18 2022-01-18 0001716947 ENSC:CommonStockParValue0.0001PerShareMember 2022-01-18 2022-01-18 0001716947 ENSC:WarrantsToPurchaseOneShareOfCommonStockMember 2022-01-18 2022-01-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 18, 2022 (January 14, 2022)

 

 

 

Ensysce Biosciences, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38306   82-2755287

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification Number)

 

7946 Ivanhoe Avenue, Suite 201

La Jolla, California

   92037
(Address of principal executive offices)   (Zip Code)

 

(858) 263-4196

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   ENSC   The Nasdaq Stock Market LLC
Warrants to purchase one share of Common Stock   ENSCW   The Nasdaq Stock Market LLC

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On September 24, 2021, Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) entered into a Securities Purchase Agreement (the “SPA”) for an aggregate financing of $15 million with institutional investors. A first closing under the SPA occurred on September 24, 2021 and was reported in a Current Report filed on September 27, 2021 and a second closing under the SPA occurred on November 5, 2021 and was reported in a Current Report filed on November 10, 2021. At the first closing, the Company issued to the investors (i) senior secured convertible promissory notes in the aggregate principal amount of $5.3 million for an aggregate purchase price of $5 million (collectively, the “Notes”) and (ii) warrants (collectively, the “Warrants”) to purchase 361,158 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) in the aggregate. At the second closing, the Company issued to the institutional investors referenced above, (i) Notes in the aggregate principal amount of $10.6 million for an aggregate purchase price of $10 million and (i) Warrants to purchase 722,317 shares of the Common Stock in the aggregate. Under the SPA, the conversion price for converting Notes into the Company’s common stock is $5.87 per share, subject to adjustment under certain events.

 

On December 27, 2021, the parties to the SPA agreed to a Letter Agreement amending the SPA (“Letter Agreement”). Under the terms of the Letter Agreement, holders of the Notes were entitled to convert notes at an exercise price of $4.50 per share of Company Common Stock for fourteen trading days, commencing December 28, 2021 and ending January 14, 2022. Under the terms of the Letter Agreement, following this period, the initial conversion price of $5.87 will apply. There was no change to the exercise price of the Warrants. The Letter Agreement also included certain conditions that the Company must satisfy in connection with the transaction. The Letter Agreement expired on January 14, 2022.

 

On January 16, 2022, the parties to the SPA agreed to a Second Letter Agreement amending the SPA (“Second Letter Agreement”). Under the terms of the Second Letter Agreement, holders of the Notes may convert notes at an exercise price of $3.80 per share of Company Common Stock commencing January 18, 2022 and ending February 11, 2022. Following this period, the initial conversion price of $5.87 will apply. There is no change to the exercise price of the Warrants. The Second Letter Agreement also includes certain conditions that the Company must satisfy in connection with the transaction.

 

The Company has registered with the Securities and Exchange Commission (the “SEC”) the resale of the shares of Common Stock issuable upon conversion of the Notes as well as the shares of Common Stock issuable upon the exercise of the Warrants pursuant to the Registration Rights Agreement, dated September 24, 2021, by and among the Company and the purchasers signatory to the SPA.

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

 

The information provided under Item 1.01 in this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

 

Item 3.02. Unregistered Sales of Equity Securities

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. The Notes and the Warrants were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”), based on the exemption from registration afforded by Section 4(a)(2) of the Securities Act.

 

2

 

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.   Description
4.6   Form of Senior Secured Convertible Promissory Note issued by the Company pursuant to and in accordance with the Securities Purchase Agreement (incorporated by reference to Exhibit 4.6 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on September 27, 2021).
4.7   Form of Common Stock Purchase Warrant to be issued by the Company pursuant to and in accordance with the Securities Purchase Agreement (incorporated by reference to Exhibit 4.7 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on September 27, 2021).
10.1*   Securities Purchase Agreement, dated September 24, 2021, by and among the Company and the purchasers signatory thereto (incorporated by reference to Exhibit 10.1 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on September 27, 2021).
10.2   Registration Rights Agreement, dated September 24, 2021, by and among the Company and the parties signatory thereto(incorporated by reference to Exhibit 10.2 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on September 27, 2021).
10.3   Subsidiary Guarantee, dated September 24, 2021, by and among the Company and the purchasers signatory thereto(incorporated by reference to Exhibit 10.3 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on September 27, 2021).
10.4*   Security Agreement, dated September 24, 2021, by and among the Company, EBI OpCo, Inc., Covistat, Inc. and the other parties signatory thereto (incorporated by reference to Exhibit 10.4 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on September 27, 2021).
10.5*   Patent Security Agreement, dated September 24, 2021, by and among the Company, EBI OpCo, Inc., Covistat, Inc. and the other parties signatory thereto (incorporated by reference to Exhibit 10.5 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on September 27, 2021).
10.6   Letter Agreement, dated December 27, 2021, by and among the Company and the parties signatory thereto (incorporated by reference to Exhibit 10.6 filed with Ensysce Biosciences, Inc.’s Current Report on Form 8-K on December 27, 2021).
10.7   Second Letter Agreement, dated January 16, 2022, by and among the Company and the parties signatory thereto.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Schedules, exhibits and similar supporting attachments to this exhibit are omitted pursuant to Item 601(b)(2) of Regulation S-K. We agree to furnish a supplemental copy of any omitted schedule or similar attachment to the SEC upon request.

 

3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 18, 2022

 

  Ensysce Biosciences, Inc.
     
  By: /s/ Lynn Kirkpatrick
  Name: Dr. Lynn Kirkpatrick
  Title: President and Chief Executive Officer

 

4

 

 EX-10.7 2 ex10-7.htm

 

Exhibit 10.7

 

EXECUTION VERSION

 

 

 

January 16, 2022

3i, LP

140 Broadway FL 38

New York, NY 10005

 

Anson Investments Master Fund LP

c/o Anson Advisors Inc. 155 University Ave., Suite 207

Toronto, ON Canada M5H3B7

 

Anson East Master Fund LP

c/o Anson Advisors Inc. 155 University Ave., Suite 207

Toronto, ON Canada M5H3B7

 

Re:    Second Amendment of the Senior Secured Convertible Notes

 

Dear Sirs:

 

Reference is made to (a) that certain Securities Purchase Agreement (as modified from time to time, the “Purchase Agreement”), dated as of September 24, 2021, between the Company and the purchasers identified therein, which are the same as the three addressees listed above (collectively, the “Investors”) and (b) the Senior Secured Convertible Promissory Notes (as modified from time to time, the “Senior Secured Convertible Notes”), and (c) and the other transaction documents, as modified from time to time, referred to collectively, as the “Transaction Documents”). Capitalized terms used but not defined herein shall have the meanings given to them in the Purchase Agreement, or if not defined therein, in the Notes, or if not defined therein, in the applicable Transaction Document, in each case as of the date hereof.

 

 

 

 

This second letter agreement (this “Second Letter Agreement”) confirms our recent discussions about, among other matters, certain modifications to the Senior Secured Convertible Notes.

 

  (1) The Fixed Conversion Price as identified on the facing page of the Senior Secured Convertible Notes and in Section 4(b) of the Senior Secured Convertible Notes shall be $3.80 for the Trading Days of January 18, 2022 through and inclusive of February 11, 2022. Any conversion which occurs shall be voluntary at the election of the Holder, which shall evidence its election as to the note being converted in writing on a conversion notice. Thereafter the Fixed Conversion Price shall revert to the original Fixed Conversion Price of $5.87, subject to any future adjustments as provided in the Senior Secured Convertible Notes. To be free from doubt, the Exercise Price set for in the Warrants shall not be modified pursuant to this Second Letter Agreement.

 

The Company hereby agrees, for itself and its Subsidiaries, that the Guarantors continue to guaranty, pursuant to the Guaranty, as primary obligor and not as surety, the full and punctual payment when due of the obligations owing under the Notes and the other Transaction Documents as modified hereby (as limited by the original terms of the Guaranty) and that the terms hereof shall not affect in any way their obligations and liabilities, as expressly modified hereby, under the Transaction Documents. The Company, for itself and its Subsidiaries, hereby reaffirms (a) all such obligations and liabilities and agrees that such obligations and liabilities shall remain in full force and effect and (b) the security interests granted under the Transaction Documents and agrees that such security interests shall continue to secure such obligations and liabilities.

 

This Second Letter Agreement is a Transaction Document and is limited as written. As of the date first written above, each reference in the Purchase Agreement or any other applicable Transaction Document to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of like import, and each reference in the other Transaction Documents to such Purchase Agreement or other Transaction Documents (including, without limitation, by means of words like “thereunder,” “thereof” and words of like import), shall refer to the Purchase Agreement as modified thereby, and this Second Letter Agreement and the Purchase Agreement shall be read together and construed as a single agreement. The execution, delivery and effectiveness of this Second Letter Agreement shall not, except as expressly provided herein, (A) waive or modify any right, power or remedy under, or any other provision of, any Transaction Document or (B) commit or otherwise obligate any Purchaser to enter into or consider entering into any other amendment, waiver or modification of any Transaction Document.

 

All communications and notices hereunder shall be given as provided in the Transaction Documents. This Second Letter Agreement (a) shall be governed by and construed in accordance with the law of the State of New York, (b) is for the exclusive benefit of the parties hereto and the other Purchasers and beneficiaries of the Purchaser Agreement and, together with the other Transaction Documents, constitutes the entire agreement of such parties, superseding all prior agreements among them, with respect to the subject matter hereof, (c) may be modified, waived or assigned only in writing and only to the extent such modification, waiver or assignment would be permitted under the Transaction Documents (and any attempt to assign this Second Letter Agreement without such writing shall be null and void), (d) is a negotiated document, entered into freely among the parties upon advice of their own counsel, and it should not be construed against any of its drafters and (e) shall survive the satisfaction or discharge of the amounts owing under the Transaction Documents. The fact that any term or provision of this Second Letter Agreement is held invalid, illegal or unenforceable as to any person in any situation in any jurisdiction shall not affect the validity, enforceability or legality of the remaining terms or provisions hereof or the validity, enforceability or legality of such offending term or provision in any other situation or jurisdiction or as applied to any person.

 

 

 

 

This Second Letter Agreement is expressly conditioned on the following conditions precedent:

 

  (1) The Company shall file before 8:30AM New York time on January 18, 2022, a current report on Form 8-K with the Securities and Exchange Commission disclosing the material terms of this Second Letter Agreement contemplated hereby, including such Second Letter Agreement as an exhibit thereto;
     
  (2) The Company shall file with The Nasdaq Stock Market LLC such notice or application or shall have determined that no such filing is necessary;
     
  (3) The Company shall have confirmed with each signatory to those certain voting agreements entered into in accordance with Section 4.11(b) of the Purchase Agreement reaffirming that such voting agreement is in force notwithstanding the provisions of this Second Letter Agreement or shall amend and restate each voting agreement to approve this Second Letter Agreement and shall supply written proof to the Investors, which may be in the form of a forwarded email from each signatory;
     
  (4) The Company’s Board of Directors shall have approved this Second Letter Agreement and all undertakings thereto in all respects and shall provide written evidence of the same to the Investors by January 18, 2022;
     
  (5) The Company shall file prior to 9:30 AM New York time on January 18, 2022, a prospectus supplement to that certain registration statement on Form S-1 (File No. 333-260478) providing for the terms of this Second Letter Agreement and/or such other Post-Effective Amendment as may be required, which filing shall have been accepted and effective as may be required or applicable;
     
  (6) The Company shall have verified and confirmed with its transfer agent that there are no impediments to the issuance of shares as a result of this Second Letter Agreement: and
     
  (7) The Company shall ensure that appropriate disclosure of this Second Letter Agreement is made to its stockholders in relation to that special meeting of stockholders to be held on January 26, 2022.

 

Kindly confirm your agreement with the above by signing in the space indicated below and by PDFing a partially executed copy of this letter to the undersigned, and which may be executed in identical counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement.

 

  Very truly yours,
   
  ENSYSCE BIOSCIENCES, INC.
     
  By: /s/ Lynn Kirkpatrick
    Dr. Lynn Kirkpatrick
    Chief Executive Officer

 

AGREED AND ACCEPTED:  
   
3i, LP  
     
By: /s/ Maier Tarlow  
Name: Maier Tarlow  
Title: Manager, On Behalf Of The GP  

 

[Signatures follow on next page]

 

 

 

 

Anson Investments Master Fund LP  
     
By: /s/ Amin Nathoo  
Name: Amin Nathoo  
Title: Director, Anson Advisors Inc.  
     
Anson East Master Fund LP  
     
By: /s/ Amin Nathoo  
Name: Amin Nathoo  
Title: Director, Anson Advisors Inc.  

 

 

 

 

 GRAPHIC 3 ex10-7_001.jpg begin 644 ex10-7_001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#L_P#A<^B8 MS]BO,?[HH_X7-HG3[%>_]\BK-Y\(?#EQDP?:;9ST*29 _ YK@O&OP['A/35O MXM0:XC:41['3##(..0>>GI73"-&32UN<[=2.K.U_X7/HG_/C>_\ ?(H_X7/H MG_/E>_\ ?(KP\\ G.<#M7JF@_":TUC0K/4'U.>-KB,.5"@@9[5[T4E+7,;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 44E&: %HI,T4 %><_&7_D48/^OI/Y M&O1C7G7QE_Y%&#_KZ7^1K2E_$1G4^%GA1^Z<^AKZ:\#_ /(DZ1_U[K7S*?N' MZ5]-^"/^1*TC_KW6NG%?"C&A\3.@Q1117$=0QE!!S^(KQ'P]:C0/C1)8@A4= MY @/&58$C'XYKW"J;Z?927BW;VL)N$^[*4&X?CUJX3Y4T^I$H\S3[%P'BEI, M4M9EA112$XI@+129HR#0 M%(3BC-(!:*3(-+0 4444P"BBC- "9I'=%-\GBJ^F(D5-C M*H'S'&<^U=#I7AO5;:[MKN?Q/>W,:X9H'0!6!'0D5'\3/^10?_KXB_\ 0A75 MV_\ QZQ_[@_E3 \T\+>(=4_X36>&^O)9K&YFE@A#D81U.0!QW%=EXNU.32_# ML\ENQ%U*1#!CKO8X']:X""!_^$>U?4H 3/INLFY4CJ " P_(FNKO;A-?\5:3 M#%\]M:6YOY.X#,,(#[]30!)\/;S4+_PP9+Z[DFN$N)(V=R,G!'M15;X<_P#( MM3BUYU\9/^10@_Z^E_D:TH_&B* MGPL\*;[I^E?37@@_\45I'_7NM?,IY!'?%>[^%?'/AK3_ MIMI=:O;Q3Q0A7 M1LY4^AXKIQ*;BK:F%%I-MGH=%+[7PA9V\]Q!).TS[%C0@'@9)YK=M)Q=6D-P%VB5 X![9& M:\(^)_B6S\0:Q:)IURMQ:V\1^=,X+D\]?0 5[CI'_(&LO^N"?^@BKG348IO= MDQFY2:Z%^F,P5220 !DDT^HI$66)XV&592I]P>*Q-#F]0\?^&--!\W5(78?P M1?.?R%AT?ACQUX@U_QMIT%W M>!;9W.88E"J1C@$]37LUW=V]C;/<74Z0Q(,L[L /J:^8_#>I2:1X@M+Z&V: MYEB8[(EZL2, <5Z$?"?C#QU=+=:_<_8+,G*V_P#=';"^ON?$ M6@7?AK6)-/N\,5^9) .)%/0C^M:?P^UR30_%MHV\B"Y803#/!!/!_ UI4HPE M'FAN3"I*,K2/I*BDS2UPG4-SQ7.>*/&.F^%+4-=L9+B3/E6ZE:B^'OB@J"0:P-_789QU]/2O1] M$T6VT'28+"T0+'&N&(ZNV.6/J2:U<8IRJK:*5@5/JV[GBK>/O&?A6[6#7[)) ME/0R+MSZ[6'!KO/#'Q T?Q,ZV\3-;WI&?L\O4^N#T-:WB#0;3Q!I$UA=HI#* M2CXYC;L0>V*\/\!VTFG?$RTM)QB2&22)AC'(!%4E&I%NUFB6Y0DE?1GT#=2- M%:S2(,NJ,RCU(&17ATGQ;\41,5DAMD()!#1$8^N:]XQ^-59]/L[H%;FT@E![ M21AA^HK*G.,;W5S246]G8\0'Q@\2'HMF1ZA#2'XP>)!U2S '7Y*?\5O#,.C: MO;WUG D5I=+M*QKA5<=>.@R#^E., MYKMC&G*',DCFVZ?-)N4 M/%:OAGXE>(=9\26%C-! ;>68+*R1'(4@\YZ"JGPD\.V^I7E[J%[;QSP0J(XU MD4,I8\DX/7BO:(+2WME"P6\40'0(@'\JJK*G%N*CJ334I)-LGKE?%GCC3?"D M0CFS->.,I;H>?J?05NZM?QZ7I=U?2_<@C+D9ZXZ#\3Q7S6CW/BOQ7&;B5C-? MW 5F)R54G&![ =JBC3YVV]D74GRJRW9V,?B_QYXON"NC1&"$'K"H"J/=CWK4 M_P"$?^)\2>8NLJSXSL,P//ISQ7INF:9:Z3I\-E9QK'#$H4 #]3ZYJ]@TG5UL MDK J;:NWJ>++\1O%OAB\%KX@L%F '.]=K$>H(X->A>&/'&D>*08K61HKM5W- M;R## >H]1]*L^*O#MMXET.:RF4>8%+0R=T?M@_I7D'PM1K7X@K;RC$BQ21L/ M0@\_RJ[1J0;M9HF\H22;NF?0%%%)FN/05F_$[QK)HEH-*T^0+?7"9=P>8HSQD>Y[5YAX-\,3>+->%LS,MLG[RYDR2 M2,],]R>GYUO3HIQB6RV\0."8UX7ZL>]2W7A7 MXELOVAM6EDD'\$=WM(^F.*]:T_3K32K*.TLH%A@C&%51C_\ 6:NXI>V5_=2L M/V;:U9\\#QOXT\/7AM[R[F$B'F*[3<3^)[>XKT3P?\3[/7IDL-1C6SOGX0@Y M20^@/8^QH^+FDP77A,WQC'GVLBE7 YVDX(/J.G%>%!F0AU;:RG(8<$$=#]>E M;QA&K!NUF9.4J, MI-6U*32+24BPM6(DVG_6R#KGU Z8]:ZKX7>$(;+3(]?R1DYN4K1,M(_BGK8$WF&R0]%)6(X^G6JE_#\4-$B,\ES//& MHR3&XEP!W(Z@5[9BC%3[;79#]GYL\2T;XP:I;2"/5[6.YBSAGC&UU]>.E>KZ M%XATWQ#8BZTZ<2*.&0\,A]".U>9?%GPI#;QIK]E$(PS".Y5!@$GHV!WSP:X# MPWXAN_#6L0W]LY"@@2QY^61,\@C^7H:V=*-2/-#1D*I*$K2V/H7Q9HLWB#1# M802I$YE1]S D8!!/2MJ)=D2(3G:H&145G=17UE#=0MNCF0.I]B,U9KDV.BYS M.@^&FTRRU:UNI(Y4OKB23"@X"L,8.>]1^$/"LWAVUNEN;D7$\Q"K(,\1@85> M?2NKHQ0!SOA;09]!TE[26='9IY);@DT<]**DVF>8_\*6UC_H)VG_? M+4O_ I?6.^IVO\ WR:]MQ17*\14>[-_91['S!XH\,W?A;5$L+N5)6>,2*\8 M(!&2,<]^*^D]+ 72K,#M"G_H(KS+XS:5)+#IFH0PN[(QB?:I/!P1G'T->F:4 MV_2+-CQF%/\ T$4ZTW.$6Q4X\LFB]1117.;#:\2^-'_(?T__ *]S_.O;J\2^ M-'_(P:?_ ->Y_G71AW^\1C67NLYGX>@'QWI64?&C3E:QT[4@OS1R&)CW((R/U%>/PN8IX MW7@JZG\B*]T^+_\ R)@/<7"#^E?-MK. M]IH(KLPK33BSGKIIIH^E]!UNT\0:1!?VDBL'4;U!Y1NZGT(-:]?*^CZ] MJ>@71N=-NFA8_>4'*M]1T(KT32?C-.FV/5M-#@<&6W.#_P!\GC\C6<\-).\= M45"M%K70]B/45Y=-X/U6+XKIK<%J&T]I1(T@8#!(PQ(SGK76:+XZ\/ZZ52UU M!$F/_+*;Y&S^/!_"NFSWK%.5-M-;FC2E9]A:.M+14%G,^.-"'B#PK=VH4&=% M\V$]PR\C'U&1^-?-; @E6!!!((]".M?7':OG3XC:#_87BV?RTVVUV#/%@<#) M^8#Z'^==F%GJXLYZ\;V:/5_AIKO]M>%(4E;=<69\B3/4@?=/XBNT[5\_?"W7 MO[(\5I:ROMM[X>6P)X##E3_2OH*L:\.6;\S2G+FB&:\.^,FJBXUZTTY6RMK$ M7< _Q,>/QP*]KFE2"%Y7.U$4LQ] !7SO:))XV^(X+ F.YN2[XZ"-3_@/UJL. ME=R>R)JO1+N>P?#O1CHW@VSC=<33CSY/4%N0/P&*ZWM3$1414484 #V%2=Z MPDW)M]S5*RLWNJ@X]"PKP#3;U],U2UOD&6MYED '?!&1^-?3F MO:6FM:'>:=)TGB*@^AZ@_F!7S#>V5QIM]-9W2%)X&*N",$$=_P >#^-=F%:Y M7%G/7NFF?3^CZK::WIL-]9R+)%*H.0>A[@^X-:-?+FB>(]5\.W!FTVZ:/&FG[NI<:T6E<]>[UY?I?@[6 M-.^*DNK+:C^S7DD82AAP&'IG/6NPT7QGH6O "RU"/S3_ ,LI/E;\CU_"NASQ M6*E*%UW+:4K/L+VJ*:1887D\;79L?!NJS@D$6[ $>IX_K4I M7:13=D?/.OZK)K6OWNHR,3YTI*9[*.%'Y"O:?A1I"6'A".\*XFOF,C'OM!( M_G^=>!'(C(S@@'\.*^H/""JGA'2E48'V9./PKMQ'NP21ST=9-FWBEHHKA.DY M?QWHU[KWA>?3[ (9Y77&]L #/-<-I_P49D!U+5<$]4@3I^)_PKV&DK2-2459 M,AP3=V4M-L(M+TVVL82QC@0(I;J0*SO%^J'1O"FH7J'$BQ$(?]H\#]36[7G/ MQBNVA\*06X)'VBY ..X )_I137--)]6.3M%L\7TZV6^U2V@ED55FE42.YP " MOG7PSI46M^(['39W:..X?:S)UQ M@GC\J]4_X4MH^/\ D(W?Z5U8CDNE)VL<]'F2;2.[_P"$AT;_ *"MI_W^'^-' M_"1:-_T%;/\ [_+_ (UPG_"E-([:C=_D*3_A2FD_]!*Z_P"^17/RTN[->:?8 MZ+Q3J6BZGX7U*T.HVC[X&P!*"<@9'?KFOG09(&;P%I+2')$97)[@,0/TKJZS= M$TN+1-(M=-@8M% FU6/4]^?SK2KED[MM'1%65A:***0PHHHH 0UYU\9/^11@ M_P"OI/Y&O137G7QD_P"11@_Z^D_D:TI?Q$9U/@9X2?NGZ5].>!_^1*TC_KW6 MOF,_=/TKZ<\#_P#(E:1_U[K71BOA1C0^)G04445QG4,9%<88 CT(S2@ # QC MM3J3BD "BN3\0^.;/P_K=EI+VTMQY_G7MU>(_&?_D8-/\ ^O<_SK?#_P 1&5;X3F?AY_R/FE_]=#_( MU])U\V?#S_D?-+_ZZ'^1KZ3JL5\:]!8?X0%+2"EKF-SSWXP_\B6/^OA/ZUX/ M_$/J/YBO>/C!_P B8/\ KX2O!_XA]1_,5WX?X/O.2M\7W'U;IG_(*L_^N*?^ M@BKE4],_Y!5G_P!<4_\ 015RN![G4M@KE_%/@G2O%4.;E#%=*,)<1\,/8^H] MC6SJFKV&C6GVK4;E+>'(7>YP,GM4UI=P7]I%=6TBR02J&1UZ,#T(IIR6J!I/ M1G@.N?#/Q#I!9X;<7UL,D/!]X#U*GFN/ECD@D*3(\; X*NI!!_&OK?M67J6@ MZ7K$9CO[""<'NZ#(^AZBNF.):^)7,)4$]CY:!(((SD'@@\CZ5W?@[XD:CHES M%:ZE,]WIQ(4ESEXAZ@]P.XK7\9_"Q+*SFU'02[1Q@M+:L23@=2OTZXKRTNA.%:+ZF3YJ;5SZS@FCN8$FBX!R/T-=S7G27+)H[(NZN%<'\5- _M;PLUW"F;FQ/FKCJ5Z,/RY_"N[J.6 M))HGCD 9'!5@>X/&*(R<9)H4E=-'R;'(T4B2Q,0Z,&4C@@@Y%?3?A76EU_PY M9Z@I!9T D [.."/SKYY\4:*_A_Q)>Z>P.Q'W1'U0\@_E7=_!W7?(O;K1)G^2 M7]]"">C#J/Q7BITU)'-2?+*S.S^)FL_V1X-N%C?;/=D01XZ\\D_D#^=< MI\&=$ 6]UJ13_P ^\)([#EB/QQ61\6-6;5?%4&DVQ+BT 0*.AE;''U''YFO7 M/#.CIH7AVRT]0,QQC>>Y8\DG\:Q?N4DNK-5[U2_1&T*6BBN8V>KDO%O@+3 M/%0$TFZWOE7"W$8&2/1AW%;FK:WIVAVZ3:E=QVT;MM5G/!/I5NVN(;NVCN(' M#PR*&1AT(-5%RC9HEI/1GSWKGPX\1:*S.+4WEN"<26_S''J5ZBN2=6C8I(K( MP."K @C\#7UOVK*U/P[I&LH5O]/@FS_$5 8?B.:Z8XIVM)&,J"Z,^7 2'#*2 M&'0@X(^A%>A^"/B5?:9=Q6&L3M<6#D*)7.7BSP#GN/;M4WC?X9?V1:R:GHQD MEMH^98&.6C'JI[CUSS7FQP1['K70G"M&R,O>IO4^M4=9$#H0589!'>N5^)() M\!:ICM&"?ID4GPXU"34? ^GR2-N>(&$GN0IP/TK1\86;7_A#5+95+,]NV .Y M S_2N!+EG9]&=3=XW[H^9&&01CJ,5]+^!;@77@G29L)/)'M7&_&"T,_@^.< M*3Y%PK''8'@_SK6CI439$]8NQY%X2NELO%^DW#' 6Y7/XY&/UKZ?'2ODE':* M19%)#(P8'W!R/Y5]1Z#J*:OH5E?(MJ,))?&C_D/Z?_UP/\Z](N?'GAFTR)=7M\CJ$)8_H*\A^)7B/3?$FKVD^F3- M+'%$49BA7G.<#-.A&2FG8FM).-DS/^'O_(^:7_OG^1KZ3KY@\(ZE:Z/XJL+^ M\8I;Q.2[ $X&,=.M>ZVWQ#\+78!35H5/I("I_45>*BW)-(5!I1U9U5%06]Q% M=VZ3P2K)$XRK*<@CZUFZEXGT3293#?ZE;P2@ F-F^8?@*Y4G>R-[Z7.7^,'_ M ")@_P"OA*\'_B'U'\Q7J_Q)\:Z%KOA_[!IUV9YQ,K8"$# Z\D5Y1U(^H/X9 MKT,/%J&J.2LTY:'U;IG_ ""K/_KBG_H(JW7$:3\1_"SV-M"^I".1(E5A(C M@ 'G&*Z;3M;TS5U8Z??0W.W&[RV!(SZUP2C)7NCJ4E8YSXI6ZS^ KPDQ"7P/JR_\ 3 G\N:\8\ ^+SX5U M8^>&:PN0%F ZJ1T8#V[CTK>$'.D[;IF4I*-1-]CZ-[454L;^UU&T2ZLYTGA< M95T8$'_Z]6^MAKYB\7V$6F>+M4M(,"))B4&> #SC\,U]">(O$ M=AX;TY[N]E4':?+B!^:1NP KP'3M-U'QSXJE\M3ON)3+-+C*Q*3R2?IQBNO# M7C>3VL<]>SLEN>N?"6RDM?!22OD?:)FD4'TS@'\<5WM4].L8=,TZWL;<8B@C M"*.^ ,5H3Z1JEMJ%J?WMNX=<]#QT/M7U!JNGQ:KI=S83@&.>,H?QKY=U&QFTS4;BQG M4B6W35;M=\<#FYD)Y!%H!*@%U=?OI?49' _ ?SKK^*YJT^:6FRV-J<;1 MUW8^BBBLC0\\^,%J)_!@E &8;A#GT!!!_G6G\.-334O!-B0?G@4PN/0K_P#6 M(IOQ/3?\/]2('W0K?^/"O+/AYXS7PQJ#VUX3_9UT1O8 DQL.-V/3GFNB,'.C MIT9C*7+-7V9]"TAJO:W<%Y L]M*DL3C*NC @_C5BN=]C7OVD=AX@U"UB/[N*X=5YZ#.1_.OHGQ/XIL/#.FO<74J^<5/DP@Y9V[ M8'IGO7A'A[0[[QKXD8;6*22F6ZFQPBDY(SZGH*ZL->*DDV[?N[A1W M0]3CU!YKUCXE>#3X@L%U"P0'4+92-H_Y:IU*_4=17A+(R2,C*RLI*LK#!!'8 MBO0IR56#3WZG)-.G*Z/K&WN(KJWCGA<=E='1&M%]3TX]*Q_$ M6OVGAO2);Z[? 4$(G=V[ 5P-]\:K41D6&ES.^.#,P4#ZXS7"/=ZU\0_$]K;W M4I9I&PJ("$A3J2!VX[GO3A0=[RT2"55;+<[GX<:7-XI'CE4JZ,58$<@C@C'L:]4^$_BV*V5O#]]*%#,7M78 MX&3U7/UY'U-'Q,\!S+CQI;W074+=1@>82) /9AU_&NV@^,NA/& M#/:7L;XY 0$9]CFN.5"<7MDYK,UK6['P_ISWM_,$C7.T#[SGL .Y MKSO4_C/:B$C2]-F>0C :X(51^ )S7*Z3I^N_$W7Q-J$[?8X6_>R $)&/[JCI MD_I3C1>\M$)U%M'5G?\ @#7-?\1ZEJ.J7>(](D.+>(CD$'^$]QCK[FO0ZJ6- MC;Z;90V=K&(X(E"H@Z "K7:LI--W2LBXII:CJ***104444 >1?\ "DD'36F' MTB%'_"DE_P"@T_\ WZ%>N45K[>IW,_91['D?_"DE_P"@T_\ WZ%'_"DE_P"@ MT_\ WZ%>N8HH]O4[A[*/8\C_ .%)+_T&7_[]"C_A22_]!I_^_0KUVBCV]3N' MLH=CR+_A22?]!E_^_0I/^%)+_P!!I_\ OT*]=Q11[>IW!4H]CFO!_A2/PGI4 MEFLYN'DE,C2%0,]@,>PKH)XO.MY(LXWJ5SZ9&*EQ163;;NR[)*QY'_PI*/)( MUEN2?^6(H_X4FO\ T&G_ ._0KURBM?;U+;D.E%]#R/\ X4DHZ:T__?H4A^"* M$$'66Y&/]2*]=HH]O4[@J45T,O0-*&BZ':::)?-^SILWD8SSGI7'>*?AI3BFK,\C_X4DO;6G_[]"C_ (4DG_0: M?_OT*]M=G12E6G)6;T&J<4[I$%S;0W=M);W$:R0R*5=&Y!'I7F^L?!S3KF1I= M+NY+,G)$3#<@/MW KT^BIC.4'=,;BI;GB$/PZ\;Z#,7T>_0\YS#,4!^H/%:2 M:?\ %:XC\I[Q(E[N9%S^8KURD_"K=>3W2^XGV:75GDUM\)-1U&Y%SX@UMYFS MDB/+-],GI^%>BZ%X>TWP[9"UTVW$2?Q,>6<^I/E-1/(L:L[$*J@DD]@.M,#/UO5[70=*GU&[;$42Y [L>RCW)KQ/PK M87/COQY)J5ZF84D%Q/QP /NJ/R'Y4WX@^+G\4ZREC8[FL87VQ*/^6KDXW8^O M KUGP+X93PQX=BMG4?:Y?WEPP[L>WT'2NA+V5.[W9@W[25ELCJ !@ >@IU M9.MZ_I_A^VCGU"5HXY'"*0I.3Z<5I1NLL22)RK@,/H>:YSG6&L MVNDSR,+NZQY2A<@YSU/;H: +M]8VVI6::M\&K.9V?2K M][<$Y$4HWJ/8'KBO5:*J,Y0V9,H*6YXA!X \=Z#(3I%\A&23Y,^T'\#6DNE_ M%6[01R7R0)W?S%!_3FO7**MUF]TKD>S7=GDMI\(;N]N?M/B#6WG<_>$>23[9 M/3\*](T?1-/T&P6STZW6&(P)*-^.>*S/^%7>+-V/[/BZ]?/7%?1&**V6) MJ(R=&+/#-/\ @WK=PX-]=6UJF>0I+MCVQQ7H_A7P)I?A1GG@:2>[==K32'G' M7 '0"NLHJ)5IRW9<:<8[(,4O:BBLBQI /!%<+XC^%^C:Y*US!NL;IN2T0&UC M[KTKNZ*J,G%W3$XI[GA%[\'_ !!"Y^RS6MRG8[BA_7BJ:_"?Q86 -M;*/7[0 M#BOH/%%;+$5%U,O8Q/%],^#-\\R-J>HQ1Q9!9(02Q'<9/ _"O6-*TNTT:PCL MK&%8H(Q@ #D^I)[FM "EK.=24WJRXP4=A,<4M%%06%%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%(>!FD UF"@DG '7]P/EN9U/WO]E3Z>I_"HOB/XSU MPSRZ6EI<:;8Y*M(XPTX]0PX /H#FN(\.>'KOQ-J\=A9KP3F67&1&O1SU)M^ZCLOA-X7&H:FVM7,8-M:G$((X:3'7\/YU[CCFL[2-*MM%T MRWT^T0)#"N!ZD]R?M3^*@#\6/#G R0/YF@ M#TK.!5 ZSIBS^0VH6PEZ;#*,Y_.N.^(^N7L/V+0M,=DN[]L,RG!"YP #VR<\ M^U5XOA'I7]FA9KJY-\1DS!AM#?3Z^] 'HX((!SP>F*BGN(;:,R3RI$@ZL[ # M]:\\\ :O?V6L7GA;596DDMLF%CR<#J,]QCD53U*S/C3XC7>E7MY)%8V2#;"C M8+GOCWSW["@#TFUU2PO6(MKR"5A_"D@)_*KF>,UY3X@^'CZ)##J7A8W1NXI! MF+?DD9Z@\?CGM79ZWKT^C>#'U.XC$=V(5&P]I#QC\Z ->ZU.QLFQ&:*>,20RI(AZ,C @_B*\K\,^ 4\26(UKQ#O2N@+!1DG ZDGM7FN!_PO G S]G'/\ P$4[QYJ=_J>O6?A/3)#$ M9P&G920<')QDFT2@G^=7\UYO/\)-,33R+6[N$O ME7*S%OEW#V[#\:O?#K7;O4+.[TO4G+WFGR>66;J5Z#)]01B@#LUNH'9U6>,M M']\!QE?KZ5!%J^G3SF"*^MY)1_ L@)_G7D$6GWVL?$#7-(M+AK>&ZF)N9$ZA M%.<#ZD]*T?%7PYM-"T1]5TFXN%GM<.VYADC(&00."#S0!ZYFJUU>VMD@>ZN( MH5/>1P,_3-8?AW7C<^"(-7NVRR6Y>4^I4')_'%<)H'A^?XA7=SK6M7,WV3S" MD,2''3L.P 'ZT >L6UY;7<>^VGCF3UC8'^53[AC/;UKR74=!NO ?B'3[_0S< MSV4\GERP %B![X'3!X-:OQ#UF^EN[#P[I;M'<7V&D8'!"DX R.1T)/TH [?^ MV=,\_P C^T+;S>FSS1G/YU?SG%>;_P#"H]*&G[/M5Q]OVY\\-\N[Z8Z9]\U8 M^'>M7IFO_#^IR%[JP;"LQR2N<8SWQQCVH [FXNK>UC\RXFCB3^\[ #]:CM=1 MLKW(M;N&;'4(X)'Y5Y?]@_X3OQYJ=MJ=XZ6E@Q2.W1L%@#C(_F3BI-<\!3^' MI+34_"C7;SI*%:'<"<=1^7&[0+)0<$W( ^N#4^@?$+2?['CAU:N10!0\ M5\?%?P\4/SD#=CTW?X4[Q5_R5CPY]!_,U5\->=XQ^(,OB,QLEA:#;"2.IQ@ M>_'.<' Q^9H 37@)/C)HRR]K)@)0!G SD$^W)'XUJ0_$KPZ^F?:WNMD@7+0$'=NQT'KSWH PY?D^.<8 MB/#0 OCUV'K5OQAX$O=1U3^VM#N1!>$#>I8J6(& 0>QQUS5+P';W6O\ BO4/ M%5S$4A;*09[D\8'J /UI\_B>]\+>/KN'6IYY-,N1F!CRL8)R,#T'0]Z ,J'Q MCXP\*2K%KEI)<6X."TJ\D>SC@_C6W\1M1BU7X=V]]:D^3<2HPSU'!Z^X(Q2> M-O&FAW_AR?3K*=;VYN0%1$4G:2>O^?6K;>%;FX^%4.D.G^F)")%0]=P)('UP M6 M?,! 8#I]#VQ5)-0?QO\ $2SFL&F&FZ>,M(,J&YSS]3P : +?_-;S_P!O^R*B\;Q7?ASQE9> M*;>(R6Y 2< <9'!!],@\'U% #_L7Q/S_ ,?=OP?[RXJWX&\-:]I'B&_U#5Q% M_I4?S,L@)9MV2<"M";XE>'(],-TEUOD*Y6 ##$XZ&JWPZN-;U2.]U74[F5K: M=_\ 1XFZ#G)(]NU &=X. /Q0\1$CD%N?^!5V/C(9\(:G_P!<#_,5QW@T@_$_ MQ&.,@MT_WJ[#QG_R)^J9_P">!_F* .-THLOP2E*?\\7''UK=^%X4>!K3;W>0 MGZ[JK^!;)-2^&,-FY&V>*1,]0,Y&:P/!7B2+PF]UX=UUFMFAE+1NX.WD\CZ' MJ#0!ZN2!@G YP,FO'_%2ZK/\5$CTEE6^$2^27( '!)Z^V:L^*M?3QCJVFZ'H M4CR*)@\LZ9 &/0^@'?WJSX^L+K1-8TKQ-9HTB6BK%-C).!T)^H)&: '?8?B? M@#[7;_\ ?2U+X2\+^([#QC-K&L"$^=&PD='!+,>G K77XE>&SIOVLW>U]N3 M5._..E9WP_U#6]>U+4=7O9Y1ISL5@A8_*"3GCV X^M $'BKP#?S:N^M>'KDP MW,AW21[RI+=RI]^X-9%OXX\5^%YTA\064DUOG!>1<,1GLPX)]JT;?Q3=^&?& MVHV7B&[G>SF;-O(_1%SD8'IC@T>/?%^C:MX?;3-/E%[=7#*(Q&I.TYZ@^O:@ M#T>QO(K^RANX&W13('4^QJU6-X7L)=-\,Z?9S?ZV.$!AZ'J:V: "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** .3\>0Q2Z;:"2-''VA?O*#7"?$:WA'B"W( MAC&Y%SA1SP*** /4?#D,4.@VBQ1HB[.BJ *Q-=AB/CK17,:%@!ABHSU-%% ' M57"J\$RLH92O0C->$7UK;CQFT(@B$6\?($&.OI110![CIZ)%9VT<:*B",851 M@?E7/_$"WAE\/.TD,;LIX+*#BBB@#A/AM;02:XI>&-BI.W<@.*]F'?ZT44 > M.?$ZWA364988PS=2%&37H'@>"&'P]'Y44:;CSM4#-%% %,P0_P#"R/,\I/,\ MK[VT9Z#O73:C#%-IUPDL:.I0Y#*".E%% '@=M;PGQ)5#>'+\$ CRCUHHH I^ M#$2/PQ:*B*HP>%&.]$V$,WDQ^;L/S[1G\Z** 9:^%UO"NC23"&,2MU M<*,G\:[>[1)+*97565HSD,,@T44"/ I[> >+?)$,8BW_ ' HQU]*]XTQ$BTN MV6-%10@X48%%% SF/B/;PRZ,C20QNRG@LH)% EX-101.SCH 4 ensc-20220118.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 ensc-20220118_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 ensc-20220118_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Common Stock, par value $0.0001 per share Warrants to purchase one share of Common Stock Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 ensc-20220118_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.4
Cover
Jan. 18, 2022
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 18, 2022
Entity File Number 001-38306
Entity Registrant Name Ensysce Biosciences, Inc.
Entity Central Index Key 0001716947
Entity Tax Identification Number 82-2755287
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 7946 Ivanhoe Avenue
Entity Address, Address Line Two Suite 201
Entity Address, City or Town La Jolla
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92037
City Area Code (858)
Local Phone Number 263-4196
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, par value $0.0001 per share  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol ENSC
Security Exchange Name NASDAQ
Warrants to purchase one share of Common Stock  
Title of 12(b) Security Warrants to purchase one share of Common Stock
Trading Symbol ENSCW
Security Exchange Name NASDAQ
XML 9 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001716947 2022-01-18 2022-01-18 0001716947 ENSC:CommonStockParValue0.0001PerShareMember 2022-01-18 2022-01-18 0001716947 ENSC:WarrantsToPurchaseOneShareOfCommonStockMember 2022-01-18 2022-01-18 iso4217:USD shares iso4217:USD shares 0001716947 false 8-K 2022-01-18 Ensysce Biosciences, Inc. DE 001-38306 82-2755287 7946 Ivanhoe Avenue Suite 201 La Jolla CA 92037 (858) 263-4196 false false false false Common Stock, par value $0.0001 per share ENSC NASDAQ Warrants to purchase one share of Common Stock ENSCW NASDAQ true false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 3 122 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ensysce.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ensc-20220118.xsd ensc-20220118_def.xml ensc-20220118_lab.xml ensc-20220118_pre.xml ex10-7.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "ensc-20220118_def.xml" ] }, "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "ensc-20220118_lab.xml" ] }, "presentationLink": { "local": [ "ensc-20220118_pre.xml" ] }, "schema": { "local": [ "ensc-20220118.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 2, "memberStandard": 0, "nsprefix": "ENSC", "nsuri": "http://ensysce.com/20220118", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2022-01-18to2022-01-18", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://ensysce.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2022-01-18to2022-01-18", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "ENSC_CommonStockParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.0001 per share" } } }, "localname": "CommonStockParValue0.0001PerShareMember", "nsuri": "http://ensysce.com/20220118", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "domainItemType" }, "ENSC_WarrantsToPurchaseOneShareOfCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants to purchase one share of Common Stock" } } }, "localname": "WarrantsToPurchaseOneShareOfCommonStockMember", "nsuri": "http://ensysce.com/20220118", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://ensysce.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 16 0001493152-22-001379-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-001379-xbrl.zip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

L4X&DK%"M#?'F&^.:%&2(IV1T. METZ_Q@ G]@KH8Q(!W5LF6W-WC;#)I!#C8>=<^#*_"(!6(S7>Q[+A [920MO. M-?R2AF:>.1TB*2OU?7'J^_:%J:^(\ *?ZR]"/H; MO+*%=70O;("?7> C757[\3+[P;/6@%(G>SW#XL^$TTTD'VLOV.\78=RW[?4! MNZJ?4B)H>]R@&0-W&4:@0TL&N1:X#V X)T40V?:D;0^5PO#ZF@NK^1)X29 N MI8/%4M,5UL"=M+L@AA>3"A>P6U@*PLLN6);,;V_B![KPZ=C@8?L>]$7D%PD0 M;J^O#2_X/-\W+@R;!\5FP7@SXI\_ M\#J542GH%BJO]KXO/LTG_;M"R'-*!K\=YN+F\TVMP4[.+F]J9XV+6N/&8V<7 MM9+]JIA%!'*G0/MC/=%9X_8>-^SUVRDMUF^B+^$^Y@UY"XRZS@_3,&/*XD[F M!.8\&+$?T2]?G)J[YQ]IX9,E?'T-Q?'35V5 MIK#RT[%1ZTH1X(=@\.8H!-[+()!MO$C[8V'*].^U^IE"TY)\;?7#=:-19]4+ M^*]6:UPU&_7#J1;^G4YM1B!:QO(+#439-R6-1IU%D3T6BAX98AXY;CRR+3P4 M+32NO+2P\HE+O"/+%:0%XR'E&V+U-[COQ;%T >!_1N!>X"ZC$ENXL2PR\9Z._V+W16=^[ M.JH=R_NJJA42'0%;\[_V< 7#_F0PK-J3$;O@IAO'OP0*6S;F&)'7R\=@RQ9' M=N_%F_:=E\L0T.-K+B\TX7W@2TF7XGR?36(K)[IRHBLG^B.=Z!++O4_Y^-_K M(W:9T,>M#MDY^KE55C[^GO^L"_$N3_4$L#!!0 ( M .GE)/V91EM]+2]O9VNH]U$J+23C^VGIS)2.F;\[.& MTF8=FM1-QZ6FPH)&AFX^3.X?2X.J3=O0(U7QBS](-CW6-92JPP;ARH6T*(Q4 M=6.KYD55UZ^J.U9.EHHOP2%J! WZD^I*"#/,D-WLU<^&U=WX^L.J:=>FIJ-9 M=H>Z0$/L*9_,R$FY$.HDZ3 ETA'\G6I9C[_L9RN9E?Q^QH@3G2D6-ZD38%QE M(^CVQX0":"%+/W-^59MI$SLNI*'4K]ASDBU*NT%EC3I-7M$KX/TF,U((:BBQ M+8,YL6UX24PCU;63[J#+G'BPH#B-Q=@R@RWEH*5B]4S7'L3/W"OD _H-'-L= M!PT^QD!U<-'8#^HRTQDX"DLI5@>K KFDK0275$95^$GPG\^N[AJL]#DM?D)I MA[F48!=)]K.G/WY)[%NFRTPW>07S21!%_/4EX;*^FQ8"G<9V::_;S_^73))# MG1GJ#FDP=Y=TCQ?OF/ J0 ^_'M@ @('^X 9FQI54V7]4S:XRX V M*TJ%[5SQ-?UNA_HM=YBIPO_=0X.V[C1J..P5717V ,V5.^G.4S*B3_CTFC[D MNT:;VLRYD^^X3A6=./S;:_JI("PUKZ_L&$@3.V]:ZH X[L!@7Q(:<-\.D3)= MEUSI':ARP9Y(W>I0Z!AWL$-,R&2_4^SO(L,Q& M2>!_Z:K*3"X7^"=4O.AUH"]%L'S?K:,..K2M#O(*RIVTY5K#WQ/$A%G#4$S? MB>6&1&G(#I_3D2%^9U2AD+\D0(GO-"U05]3D;!*&)\)%B1(OCP4A'4$$0@2Z ME=E@\)DC:J 2WW&X=0;0"#>Y.VVNGT$.YXW6!?Q:ZC@4X'_8;H6ZK#2<@M_3L&RL&9!R0B._9!2L M" #^1P^ET^)Y^-N=TG-3]4(%7I (P_:ZA*[HK8"4JZ!!3>+J>P[#3< &EV'[?H(YSJ?$) ME_NZDRBA$=J9$@V?T[$CAJ%-QX/[CV2N:VJ#M^DZ5U8-U$$;O,9+DW%T7FHA MC/\S6.Q5R%@QVD[/U 67@5LQQAL=1IV>S4J>_[$#=?S._*+H$-C;A/Z%,S-Q M" \)O-*;QQ@Z36/C@(,#3#F.6VS+S3IU+7N<)U^!@U$8XWH-#5IAIM71S5\- M^VN\C(X;U[%?'L'"&$(]/R/D50@GQ_?]/J>A/?S$_WWNOM;/W"4=:K=T8=-R04/[Y5(J/ZR! M,THZ^C,X_U+7'S]-P1>.@+?AR' G+IWNM0,]YS4:$S.[+C>.JQ='5Y<7F^MKE=1^BLB9?&Y[R6:3 M"6N Y8)Z%-YI=*H ,&DP#69$>Z[EPYRT]58[^/8*U;L,JG5^.%]T>)>.LWV] M>7A9/P=(>9?H8.+JW':FP!<=D\F*I?0P*L#5WCLE6!\=KI0^']WJ6P_908,9 M&O3WNTMEX?$2I:WDZ>BZ5(#AE?);*;^/JOP^!J(A7I!776TAW,R7(QW2)>CU8?+P?/1OTX>Z7/(%:+ M&S=1.A!9..MK>[KE*#K?SM\D55-)?:!0#JBQ<="G"KAVBO;,'*%JQLP8)!/0JO2YL&@W$, [XK/+,YD^!_=ZFJ M^G^_>DXAK@EVSQ3+,&C7 5#\W\2V[F?7?OT C\QV=84:/J;$UIR_3_S95=\, MNV^I$^Q=IW9TJ=6NK]I]>19Q M V9%8Q*#R[JV]8B*/QHX3 %GHE1A!GV"D&,::^BJ,Z#=_$DW(O4S@?K/<%PA MPG&'NL& /$UFQ[/7\76N>I+Y:5M?E9FY4\,Q,>E(2F:WLIG"BE<6D%H.YIDN+1.B9130"LVV8KF%)M=&-55/-5)B ME@>=KF$-,!MY29DO:EI_R89#$YKFP61I!E'P_./T5=P["G-N^Z_ED+91Y_0@ MXIR65=5FCN/].---)L4[IE?LZ:SQ_.-X\%V=F6,:,WBB5-S.%01YJH_4;%N, ME!^9V9L4%6^.[2+N_V*"ZJV9^=YQPR>*#5ZNLL(C#KMJO>R M:,)10AS&$6(??KVTKZPG,YX,V9M\K_/SI%[0MF9-AN'0B=(9%7@]01TS-6M5 MXF;$W?M+NV9;C^ -3UAORIW6CR\N3QZR5]OOM]X4#V"BM ]< )V9^J29S]A_ M6NHE!%#T?T!VMN(XK68!R8T?>G?RNJ9]=+S7LK>T;O'M^1 3V"@R>J*T+6>R M2[IN\!X^KHJS_BWB"XC7CBJUVT5WJA:)/+-J.3-=I9IB,7SX[WF#:++/+P>(G2QE9^Z],$ M'3:>^9[W8#ZS0!G5VI;YXA: ??OSNWUT:+ M='D9\8TVX1"<:&;[R3DV=ZJ93:@PU\!:&A&)QT%LF!G7\I-55BLX$J.][ MCJMK@UF"O=]FRH/(\J9="'+ ?\)\XJ;5)TUF6$](*"Q$>I*MY"G1= ,5@NZ M=G"9J0(!70MHV.D9+C69U7., 7&HJSO:@+?T&EA-F -?N\/Z6!#*U^I!/\ L MU!R@#\=;0%P2[,2[%:<*^WJK?=O^.FC.).%]TDU0L2 A-VT7<[G= MB4['S".#.:@6;VH"0"4R0=+U#LR@+L D.Y*3\T(+D)$#)WC.9$,JDOW#.I&S MF114_#2_F'<.?+X4@>&[P/J/(M6H#MKV=%##XI< @>H_!T,+UM:(5T _BFI3 M*FZ5+\O%N2J@<7@^AO89SDO V/%F-ZYZI!Q-2G)(^T3.N 6Z)Y=)B9HK];,, M]%^IG]@ME9K-T-? 0R'\E#]Z\/:EIDU:7NGGJ_*I(:G?JV_?)YIV&ZV.H M(YA?4@E-<#JO2,JI27FC^6DZY23JKM33,O##2CW%KOF.J(&JX_28_4LE5939 M^??^<KJBQ+YC:4Z5255W>"JIK7/M'\Q7A95OV&\?7ZFEB& M8S93(T0-;K'@]L=;E0-"KA;A%B^K;N0BR&;\N<<%/-%QA8\%WWN7I MR>24=]+?/9]M-<^:@ZN3!^TU^8MO?PL@O! X,NM$273B"3UVM4FZU":/V!OY MM^B/=/'N]O:['*?],XPRTZ@R)DS[ XSN1UN>6A<*_1VYW'ZH7'^]_GY2_&:\ M-Y='IBRN\U\Q[F(S[AC[ED?TM!]G3KQV9SY+?X.+1 MQ'2T[N,YZ7%8292NVO[1/>JH]*?0Y^2JBB5\&) M*QV\V#HXYLC$C)V'5[)]K>@^7DE[-]_W[O\,V\<*?IMEEY$KV*U S!OL ^ ("V^I->RK2>WC?L[72A-''0980937*82T^+; M5#WP*K$6S,!+1L='L76^=24>J$,FXF,9 \[O3SJ,C9QNP@2@R&:/N@,--=VD MIH(98E3ASSXCJ/@DN4IMU1%IZ.JD3;+L!@TVR<+;GBD2;WBVHU+5OPJ@%G=> MQXO4\\.AW+_^>EB_;>.&A0>^.7K]&@2-LN.\>WF/CC&^@3ZRT3Y.E^$2U"]#"[Q6&%NHL>+@(\QW17TWU'^2<@PM-J,/R28# ME0K0=#DN/41P,1)8"/@D1/WP$XB1WL,R,E/Q6*E+?HD4A&SK:U(J(Z7( =X( MBX?8+$*)G_M.*@S\ )U?&U!NV8Q'>*GYGT=<;J/F?00_CF&GF=2,SW-=FNMK M#=9UQ8/-LGC50]HDWDWW9.RB>[*!QYKES*Y7@_\E[:*[AQZ:5^B%"5[A)\+7 M'?B%\9PG0H>0_$!Z?2U@"K(1ZJE1*P>]H+L)\Z8MJ-E"K]9S+/$,I$;^+>4) M(,% KY%[HKH)*'1[Z&0!^^GF(X,@WG92I P-;<0)WV7\&!F_!IV0?FP#LWMLQFFZ,=5 ,=4")P\"O5.-A(#X( M (Q)+JQ'T4/^31 $S:6,: \(<+WSHR$L;/)/'N&(C@F8JG>>='TM0![9T#\! MZ*8.I'"0BE )YL'- YHD\.7Q+D8+Y!_""(9'67F_0YH-KQ&A'8P%..GRJ6Q MNS$J=P,6@;8*$PV"ZAMHS3!8>&3&8#/,A!<(0, \B+0-':!_\A9Q7FCIK_,$ MC4,K[>MKV8*T*>6WQ'*[X\H&$DX0!>$@#R03Y!IYL J=L<@I?3$V[];5_2YE4X=?4(T/B29F@NJ#* M)^)C/+*G493ES:Q4'$=T@*)QU*RO?0M+DD")X%"'1ZX<"A&X"K8%X?.GZ^'J M)5+B\6Q@UZWBD(";Q.DU[X&1$'BJHN86R;U"IA48A *<_/$H)_7'S 9$&N!< MMFP@G(K.H&7O8.82O]QC91KC36.%*5'E+?@)I)D;+X]?4&-3M%Y6!]F MXL(0GYU*!X!/+\$=/PS1MQ4R71XN1I\2&YLSF3CEX H#U((@D&(Y:M-3=.!8 M@(8:DWEA9T!PGT#WX)4,QB!%KMJ(*#2FIN5=F^%3=1P[^-575+RI!UK8=Z&& M8WFWNZ!I]&0?M;0NTOO=-G4C>KH#[!Q) MQ JI".#"MWD<:@0\.G2FHXXT1 NX) =>:]:S@CO*R(O(Y(2 MV?/! O_Z-'$5>1U?)G/"Z@>?-U5CPO)-W.+BD36 T8H86/S*=:L75X#R\? 2O]4"Y0(H2-T4>ZO"7GN[Q8*> MR!P$EYW%4@#8ZI%U,&@2W+#&KU;SGWN!+D!E!.L??O@/=7B?G-\^! J77?*S MJ0P/#D.FL0$&C9N=@Y\]W1V$+.1*7A=,7AW0K_ 77X\/22OW UXGK>B,0Q]A MH16.MN>:>&9^F"/])+QWO@R*SI35&P%/41< MK$AUW]L"'X0Z8M'=\WDZ7>'':+;5B0Y--0VW9;D.\G-=3=T0=Z0\CTT;A+K@9=&+]L MTZ:N[!),*!6HOK 0@7)D+]QOQ=-95AOTBZ.IYV)+M_D&_=!A#G*M_="RK3=U M=V5%?VE%WR%BVU _K:\-*?)1IO61;A*9\XTAL08CN-NW..N[?9LEC]N\DP=6 M:H[G:Z)SD>8:\LS[+HI)U\G,E#85YBBVSKVC^;Y.PRDS41'\SM..,T-'+E68 MU7.3BWF4:][^ "5M&_/9VZ[;=7;2Z:>GIY3#E%3+>DR7;:6M/S(GS=06M=,J M=6E:*DJ%[5PQC:DKN>VLE(> )R-GM^2M-.OGDH54V^T$ZAD/.R5A C958+I, MZ)1$B0=V$-LT1/I0PTL?V@^E#]6&Z4,8U/G!6W,06= -KQFCUX+I3PH$BBI? MTHM;-O>SS$*[,!N35X*@6T\1$F T+Y.*=SLQ+2[(%7DAGHW-!OL$.I;^TX6Y MN!+F!1+FXFN$.;+O$XB9MP:#DM1<""DNKJ1XSA(C@1/WWY4<+XP<2YFD-(T@ MORA?<]AOQ55<$,WI!!>9:B6Y\Y=<>26XBR2X\C2"&\Z4(+--E/"2T,:D=FJA ME5=".W^AS:Z$=I&$-CN5M>TU'5W5,6'QJ$?11V9L;D9V:G'-KL1U_N*:6WG' M"R6ON5=XQX/?LZR;Y&"O2BZ[^Y:0I$TH> 3C35WO4*4OS19*[F3[.[W7G%M) M]/PE.K^2Z(62Z/PT$ET#T0%.7U;!SJ\$>_Z"O=I<^O-RG97S4E[(]52[2^,G ME80XQQSA?'L /+V*._@X>O0V27[NH)"1-II^@GV=M7J&6#MO)$]3 MY)J)@];K:U!=Z]FF[K3QEAX8U^ JD)\:[@[X^3!0;_XHC@_S"?Q:I[]XQ9-W /PLZ?;WFF/\3-FD3=EQ0&XW&;D3+YW3S28 MNP%1: ^/NG'K*^ZA\Y*]T,\79^#0AC=9FQH:1 GBOC)^X,ZK@5% #\_<\OYH MSVU;-H"OK@[=_D&K6<$P;R=T.XUWYX%C.D]T%<> AS\P9QD5AG08DQ2[#V M!CLOPC2[\UPS54AZ*>VD!;!G ],DI[K]T*6NK?.7V196%_T#&(I'JQXDBP9; MQ4Y-XID5O_PAL/@3C"_KH#\!5LUFCJ[R^X81&EPTW6_K3(-X#F([OA9^J6FZ MPNSW7=Y^I]C\Y16]7.@^D3/JN*MEO1DLZ^7>NJRW% MO2Q>RQX>_Z::E#E"J MTVVW8Y2B8M)@KD_6OMK?)=4*_^4NL[5WQY_[W9 MPU=-;9Z=_G@^Z1>+[MU?_'UZY#0N*V[S_OKX0OU^T;[-M^I?OYUT?CQO MU6MVSJCNI;^GZ_5K7;5N]N]KM^<_655)*_=G]:/LDW[?WCYK7+2.C'ZZ*Q^? MLY;=K9WLG=(S>E&1OCW_..PU;NX;/Y_*S_7;0>[;CU-%OS^^Z1Q=W,B#7*U% M[]MS#\]Y1IM#9OBW8 MO:._+;=;E.O%[EQAS:^Y^N]\^)CQS[YOM7.T^NVD9=/S[XZZ>JMU.EK MQW_?Y/>VKWHPZ\:I=GO6/54*/_8<[:MYW&Y]E9ZU,M6JF;V^D]L/I M7L^Y-JKWW1]7EXV#TU,M]_3XXU;[:IWOMV__/OK9+1SWC_M?!V9%2I&UL4$L! A0#% @ YS R5$AT.G8!# &Y$ !4 ( ! M1PT &5N>(!J M2 @ "ED 5 " 7L9 !E;G-C+3(P,C(P,3$X7W!R92YX M;6Q02P$"% ,4 " #G,#)48P93_:80 99 "@ @ 'V M(0 97@Q,"TW+FAT;5!+ 0(4 Q0 ( .